Yuwell Honors Honeywell With “2021 Strategic Partnership Award” For Joint Efforts Against Covid-19 Pandemic

SHANGHAI, China, February 21, 2022 - Honeywell announced today that Jiangsu Yuwell Medical Equipment & Supply Co., Ltd. (hereinafter referred to as “Yuwell”) honored Honeywell with the "2021 Strategic Partnership Award" which recognizes the joint efforts against COVID-19 pandemic. Both parties also expressed their continuing willingness to explore opportunities on innovation and digitalization in the life sciences industry. Yuwell is able to serve the global market with oxygen generators through Honeywell’s leading technology in high-performance oxygen molecular sieves.

Since the outbreak of COVID-19, Yuwell has been actively leveraging its technological advantages to effectively respond to and relieve the impact of the COVID-19 pandemic. In addition, Honeywell and Yuwell are exploring ways to collaborate in technological innovation in the life sciences industry, including the potential development of next-generation home oxygen generators.

"With advanced technology, expertise and high-quality customer service covering the entire value chain of life sciences, Honeywell provides customers with all-round solutions including R&D and delivery, promoting the development of life sciences with innovative technologies,” said Henry Liu, Vice President and General Manager, Honeywell Performance Materials and Technologies Asia Pacific. “As a key customer of Honeywell’s high-performance oxygen molecular sieve technology, Yuwell presented the '2021 Strategic Partnership Award' as a strong recognition of our relationship. We look forward to continuing our global partnership with Yuwell to empower the advancement of life sciences and continue to contribute to pandemic prevention and control."

"Yuwell has been leading the development of the industry with high standards, and we are pleased to see the positive results of our global partnership with Honeywell. We will leverage the strengths of both companies so that we can meet the global market demand for high-quality household oxygen generators and promote the development of the medical oxygen generation industry," said Yuwell Chairman Wu Qun. "Actively fulfilling social responsibility and focusing on creating value for society is an important mission shared by both companies. Yuwell and Honeywell are committed to meeting the health needs of people around the world with continuous innovation."

As one of the world's largest manufacturers of oxygen generators, Yuwell has more than 20 years’ experience in the healthcare industry and is committed to R&D, innovation and smart manufacturing of medical devices. Its respiratory treatment solutions include medical grade and other types of oxygen generators. As one of the major medical device companies in China, Yuwell has set the industry benchmark by ensuring medical-grade oxygen quality with strict, mature and cutting-edge craftsmanship.

Honeywell UOP is one of the pioneers of the global molecular sieve industry. It first synthesized and commercialized molecular sieves in the laboratory back in the early 1950s. For 70 years, Honeywell has continued to develop and improve the performance of molecular sieves to meet the needs of application areas. In addition to the products, UOP's R&D center in China is equipped with PSA testing and experimental simulation technology to help customers quickly adjust the most appropriate operating parameters which is expected to helps customers save time in product commissioning.

Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help everything from aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable.  For more news and information on Honeywell, please visit www.honeywell.com/newsroom.